Wearable Sensors for Delirium Detection at an Early Stage (WeSen_delirium)
Key facts
- Who runs it
- University of Zurich
- Where
- Switzerland2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 47 people enrolled
- Started
- 23 Nov 2022
- Ended
- 15 Jan 2025
- Type of study
- Observational
- Record updated
- 17 August 2026
Who can take part
- Age
- 65 years and older
- Sex
- Women and men
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Female and male inpatients aged 65 years or older
- Cognitive ability to understand, consent to and participate in the study
- Fluent in German
- Provision of written informed consent
Who cannot take part
- or a delirium diagnosis made within the last 4 weeks prior to hospitalization,
- Dementia (Mini Mental Status Test Score ≤24)
- The presence of acute delirium,
- The likelihood of an alcohol withdrawal delirium (CAGE Score >1)
- Limited knowledge of the German language
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Delirium is an acute brain-organic syndrome: its clinical manifestation and form are results of a highly complex pathophysiology. Delirium is a serious clinical problem in hospitalized adults. It is the most common neuropsychiatric complication of hospitalization and is associated with high patient burden, increased morbidity and mortality, prolonged length of stay, higher costs, and institutionalization.
Read full original descriptionShow less
An early, accurate diagnosis as well as an adequate management are critical to the continued health and functional independence of the affected patients. Prevention strategies contain pharmacological and non-pharmacological interventions. However, their clinical success (effectiveness) is limited and the evidence for the use of pharmacological interventions for the prevention or management of delirium is scarce.
The prediction of delirium has become a new promising topic in clinical research. New approaches like the implementation of wearable sensors, in particular wearable accelerometer devices to record movements related to delirium are promising.
In this study, the study procedure only includes wearing a consumer-grade sensor on the wrist of the not-dominant hand.
This way, vital parameters are measured in order to identify patterns.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Wearable Sensors for Delirium Detection at an Early Stage (WeSen_delirium) - an Exploratory Study
- Record updated
- 17 August 2026